abbv-2001
abbv-2001: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: AbbVie Inc. (ABBV)
Development Pipeline (1)
| Company | Phase |
|---|---|
| AbbVie Inc. (ABBV) | Phase 1/Phase 2 |
Clinical Trials (1)
A Phase 1/2, Open-Label, Platform Study to Evaluate Safety and Efficacy of T Cell Engaging Bi/Tri-specific Antibodies in Subjects With MM
Frequently asked questions
Who is developing abbv-2001?
abbv-2001 is being developed by AbbVie Inc..
How many clinical trials involve abbv-2001?
BioSniper tracks 1 clinical trial involving abbv-2001.
Analyze AbbVie Inc. & abbv-2001 with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company